Palatin Technologies, Inc.: Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc.
Palatin finishes phase 2 trial in obesity treatment study
Inc. (NYSE American: PTN) has announced the completion of their Phase 2 clinical trial for an obesity treatment, marking a ...
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...
The Citizen6d
City of Tshwane slammed for missing financial deadline
The DA calls out Tshwane mayor Moya for missing a key deadline to submit a financial report to council, questioning her ...
The Citizen15d
Re A Spana Programme tackles crime and lawlessness in Tshwane
Sunnyside cleanup sees Tshwane mayor joining forces with TMPD, SAPS, and Home Affairs to restore law and order in the Pretoria CBD.
BioSpace16d
Palatin Provides Update on Anticipated 2025 Corporate Milestones
MC4R is a well validated target for treating obesity with MC4R agonists having demonstrated in multiple clinical studies significant reductions in caloric intake and weight loss,” continued Dr. Spana.
Vote for Week 8 Delaware HS Athlete of the Week, presented by Delaware Orthopaedic Specialists
Help decide which performance was the best in Delaware high school sports during Week 8 of the winter sports season. Vote for the Delaware Online High School Sports Athlete of the Week, presented by ...
ZDNet20d
The best security keys you can buy: Expert tested
Another option is to verify yourself using a physical security key. Also: The best home security systems, from DIY to pro installation Even if a cybercriminal has obtained your username and ...